Clinical Advantages

The Pulzar Z1 offers better, cleaner and safer technology, and its promise of excellent clinical results is now being realised by refractive surgeons around the world.

Myopia and Myopic Astigmatism Up to SE - 18D
MRSE attempted vs. achieved 1-3 months post op (N=534)

To date more than 10,000 eyes with wide range myopia, myopic astigmatism have been treated with conventional and custom ablation at ten different international sites.

Myopia and Myopic Astigmatism
Up to SE - 6D
3 months post-op (N=41)

Hyperopia and Hyperopic Astigmatism up to SE + 8D
MRSE attempted vs. achieved 3 months post op (N=51)

Excellent clinical results have been achieved, exceeding safety and efficacy benchmarks. To date of publication no major intra or post-operative complication reported.
The Pulzar Z1 as first used in 2002 by Dr Ian Anderson to treat a cohort of complex irregular astigmatism cases (J cataract refract surg 2004; 30:2145-2151)

Myopia and Myopic Astigmatism
Up to SE - 6D
MRSE attempted vs. achieved
1-3 months post-op (N=408)